Third Wave, Now An IVD Company, Is Banking On Personalized Medicine
This article was originally published in The Gray Sheet
Executive Summary
Third Wave Technologies is banking on its emerging portfolio of in vitro diagnostic products designed to tailor drug therapy to recover from substantial revenue losses in its research products business